-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
From August 16 to 17, 2022, the 2022 Ibrain Journals Academic Annual Conference and the Second International Neuroscience Summit Forum were successfully held in the form of offline and online, and the whole conference was broadcast live
After the opening ceremony, Ibrain Editor-in-Chief Professor Wang Tinghua, Director of the Neurological Disease Research Office of West China Hospital of Sichuan University, Professor Xin-Fu Zhou of the University of South Australia, Associate Editor of Ibrain, Professor Tian Xiaohe of West China Hospital of Sichuan University, Professor Giuseppe Battaglia, Department of Molecular Biomimics, University College London, Professor Loris Rizzello, National Institute of Molecular Genetics, Italy, Professor Li Tianqing, Minister of Education of the Institute of Primate Translational Medicine of Kunming University of Science and Technology, Professor Li Yunqing, a scholar of the Ministry of Education, and other experts made wonderful academic reports
Wonderful not to be missed, welcome to scan the code to watch the August 16 expert report replay!
Report content
About Ibrain
Ibrain is a global leader in research and education, an English-language open access journal
Journal publication scope and topics:
Ibrain is interested in topics related to brain, spinal cord, and neurological diseases, including, but not limited to, clinical medicine, molecular diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology, and artificial intelligence
Topics published in the journal include, but are not limited to:
Types of journal articles published:
Original article
Reviews
Comments
Case reports
Letter
Methods
Journals in 2022-2024 are exempt from publication fees (APCs
).
Currently, Ibrain is included in the international search database DOAJ, and it takes only two months
from the filing of the application to the time it is included in the DOAJ.
We sincerely welcome researchers, doctors and graduate students in the field of neuroscience to actively submit articles to the journal!
Submission Links:
https://mc.
manuscriptcentral.
com/ibra
Special Issue Call for Papers
Ibrain will publish a special issue publishing the latest basic and clinical research
on CNS injury injection materials.
It will focus on the molecular mechanisms of the use of injectable materials to repair brain injuries, basic and clinical studies of effective injection materials, and related topics
.
We cordially invite researchers to provide original research papers or review articles
for this special issue.
We can waive your publication fee and provide authors with fast access to
publication.
https://onlinelibrary.
wiley.
com/page/journal/27692795/themed-collections/injectable_materials
Related Reading
- Ibrain | Ultrasound-guided peripheral trunk block technology: a new approach that is gradually taking the stage of clinical anesthesia
- Ibrain Special Issue invites you to submit!
- Good news | Congratulations to Ibrain for being included in the DOAJ database!
- Ibrain | Study on the role of sevoflurane in cognitive function in elderly rats based on cortical microglia activation
- The opening ceremony of the inaugural medical journal Ibrain, jointly organized by Wiley Publishing Group, Zunyi Medical University and Affiliated Hospitals, was successfully held
Content | Wiley
by facilitating discovery, empowering education, and shaping talent.
For more than 200 years, Wiley has driven the development of a
global knowledge ecosystem.
Today, our high-impact content, platforms, and services help researchers, learners, institutions, and businesses achieve their goals
in a rapidly changing world.
Wiley, headquartered in Hoboken, New Jersey, USA, is listed on the New York Stock Exchange under the symbols WLY and WLYB
.
Like, watch, share, have a one-click triple!